BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6409129)

  • 1. [The effect on biologic availability of the choice of infusion material in nitroglycerin therapy].
    Cawello W; Bonn R
    Arzneimittelforschung; 1983; 33(4):595-7. PubMed ID: 6409129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of nitroglycerin during passage through two different infusion sets.
    Hansen HC; Spillum A
    Acta Pharm Nord; 1991; 3(3):131-6. PubMed ID: 1793507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets.
    Lee MG
    Am J Hosp Pharm; 1986 Aug; 43(8):1945-50. PubMed ID: 3092648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycerol trinitrate (nitroglycerin) plasma concentrations achieved after application of transdermal therapeutic systems to healthy volunteers.
    Gerardin A; Gaudry D; Moppert J; Theobald W; Fankhauser P
    Arzneimittelforschung; 1985; 35(2):530-2. PubMed ID: 3922382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response to intravenous nitroglycerin infused through polyethylene or polyvinyl chloride tubing.
    Altavela JL; Haas CE; Nowak DR; Powers J; Gacioch GM
    Am J Hosp Pharm; 1994 Feb; 51(4):490-4. PubMed ID: 8017414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin delivery through a polyethylene-lined intravenous administration set.
    Tracy TS; Bowman L; Black CD
    Am J Hosp Pharm; 1989 Oct; 46(10):2031-5. PubMed ID: 2510512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of intravenous glyceryl trinitrate: absence of rebound phenomena with transition to oral isosorbide dinitrate.
    Kelly EA; Ahmed RM; Horowitz JD
    Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):269-72. PubMed ID: 15810990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biologic availability and hemodynamic actions following administration of sublingual glycerol trinitrate. A new delivery system].
    Huber T; Merz PG; Harder S
    Arzneimittelforschung; 1991 Jul; 41(7):715-8. PubMed ID: 1772460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application.
    Treleano A; Wolz G; Brandsch R; Welle F
    Int J Pharm; 2009 Mar; 369(1-2):30-7. PubMed ID: 19027840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability of glycerol trinitrate (nitroglycerin) from an ointment preparation].
    Gielsdorf W; Schlegel E; Settlage JA; Jaeger H; Fink E
    Arzneimittelforschung; 1983; 33(12):1677-9. PubMed ID: 6421295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the availability of diazepam stored in plastic bags and administered through intravenous sets.
    Kowaluk EA; Roberts MS; Polack AE
    Am J Hosp Pharm; 1983 Mar; 40(3):417-23. PubMed ID: 6846350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Loss of intravenous nitroglycerin administered with polyvinyl chloride infusion systems].
    Barranco Ruiz F; Sánchez Alarcón MA; Lesmes Serrano A; Martínez Ruiz D; Barranco Sánchez R
    Med Clin (Barc); 1991 Feb; 96(4):129-31. PubMed ID: 1902541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
    Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
    Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a polyethylene-lined administration set on the availability of diazepam injection.
    Hancock BG; Black CD
    Am J Hosp Pharm; 1985 Feb; 42(2):335-9. PubMed ID: 3976681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion.
    Schneider JJ; Good P; Ravenscroft PJ
    J Pain Symptom Manage; 2006 Jun; 31(6):563-7. PubMed ID: 16793496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of glycerol trinitrate].
    Menke G; Woodcock BG; Rietbrock N
    Z Kardiol; 1986 Jun; 75(6):316-20. PubMed ID: 3092486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of low-dosage intravenous nitrate therapy on the anticoagulant effect of heparin].
    Bechtold H; Kleist P; Landgraf K; Möser K
    Med Klin (Munich); 1994 Jul; 89(7):360-6. PubMed ID: 7935224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The availability of nitroglycerin from parenteral solutions.
    Roberts MS; Cossum PA; Galbraith AJ; Boyd GW
    J Pharm Pharmacol; 1980 Apr; 32(4):237-44. PubMed ID: 6103051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of infusion administration set on the delivery rate and plasma concentration of nitroglycerin in dogs.
    McNiff EF; Lai CM; Look ZM; Yacobi A; Fung HL
    J Pharm Sci; 1985 Jul; 74(7):774-6. PubMed ID: 3928871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
    Daiber A; Oelze M; Coldewey M; Bachschmid M; Wenzel P; Sydow K; Wendt M; Kleschyov AL; Stalleicken D; Ullrich V; Mülsch A; Münzel T
    Mol Pharmacol; 2004 Dec; 66(6):1372-82. PubMed ID: 15331769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.